Nuliglucaemia Lucidae: Extreme Deprivation of Blood Glucose as Organic Context for Cancer Treatment with Antimetabolites

Research Article | DOI: https://doi.org/10.31579/2640-1053/068

Nuliglucaemia Lucidae: Extreme Deprivation of Blood Glucose as Organic Context for Cancer Treatment with Antimetabolites

  • Prieto Gratacós E 1*
  • García Oliver P 1
  • Alvarez RP 1
  • Redal MA 2
  • Sosa I 1
  • Laguzzi M 1
  • 1* Center for Metabolic Therapy of Buenos Aires, Argentina.
  • 2 Department of Pharmacy and Biochemistry, University of Buenos Aires, Argentina.

*Corresponding Author: Ernesto Prieto Gratacós, Chief Scientific Officer at Centro de Terapia Metabólica of Buenos Aires, Argentina

Citation: Prieto Gratacós E, García Oliver P, Alvarez RP, Redal MA, Sosa I, Laguzzi M; Nuliglucaemia Lucidae: Extreme Deprivation of Blood Glucose as Organic Context for Cancer Treatment with Antimetabolites. J. Cancer Research and Cellular Therapeutics. Doi:10.31579/2640-1053/068

Copyright: © 2020 Prieto Gratacós E, This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Received: 26 April 2020 | Accepted: 26 June 2020 | Published: 23 July 2020

Keywords: physiological ketosis; insulin clamp; competitive inhibition; metabolic cancer therapy

Abstract

The present report describes our clinical findings regarding the use of high dose intravenous insulin in cancer patients, as a means to deplete the blood compartment of glucose molecules. The purpose of this intervention is to create a favorable physiological state for the competitive inhibition of several rate-limiting enzymes within cancer cells, with structural analogues that behave as antimetabolites. Regardless of their histological origin, virtually all solid tumors reported on to date (February 2020) are found to be hypercaptant in PET-CT scans following the intravenous injection of 2-¹⁸fluoro-deoxy-D-glucose. Most solid tumors display a hypermetabolic phenotype (SUVmax ≥ 3), with marked overexpression of glucose transporters (GLUTs) in the outer membrane of their anaplastic cells subpopulations. The fact that neoplastic cells also overexpress glycolytic, fermentative and glutaminolytic enzymes up to an order of magnitude relative to healthy cells further strengthens the argument for a competitive inhibition with antimetabolites. The rationale for a deep, systemic deprivation of glucose was suggested by classical enzymological work concerning competitive inhibition (the Woods principle), and our group has shown that a metabolic intervention with structural analogues of glucose and pyruvate is strongly enhanced by a systemic suppression of the natural substrates of hexokinase 2 (HK-2) and lactic dehydrogenase isozyme A (LDH-A), followed by the timely introduction of several non- metabolizable analogues. Sustained, deep hypoglycemia (<10mg/dl) under physiological ketosis provides an advantageous context for antitumor treatment with structural analogues of glucose, pyruvate and glutamine. Data provided in this report demonstrates the feasibility and safety of the procedure.

Introduction

A favorable metabolic context for pharmacological interventions against cancer with glucose and glutamine analogues has been devised by our clinical research group [1]. This system has been safely and successfully implemented in Homo for the last twelve years in our Centro de Terapia Metabólica. We have forwarded the term “nuliglucaemia” to designate a state in which circulating blood glucose becomes virtually undetectable by standard hand-held instruments, dropping under 18 mg/dl and even to single-digit levels; whereas the adjunct term “lucidae” describes the fact that patients remain conscious, i.e. lucid, being able to answer simple questions (name, personal address, social security number), with no long-lasting adverse effects on their brain function. The realization that such a state can be achieved safely in the clinical setting is in stark contrast with commonly held beliefs within the field.

Considerable clinical experience already reported by these authors has proven that such an energy blockade of tumoral metabolism is indeed possible, without damaging the organism of the host [2]. The aim of this intervention is the onset of an acute energy disturbance in neoplastic tissues, sparing healthy organs. Such an approach is an exploitation of the functional asymmetry between neoplastic cells and healthy neighboring cells with a therapeutic aim. Evidence of such functional asymmetry is readily apparent in positron emission tomography studies (PET-CT), and references to cancer hypermetabolic phenotype are also abundant in the literature [3-6]. Robust in vitro studies have shown the respiratory quotient (RQ=CO2/O2) of ascites cells and isolated neoplastic cells to be invariably depressed even in the presence of sufficient paO2 in the culture medium, i.e. the Warburg effect [7-9]. Recently, evidence of ultrastructural pathology in human astrocytomas has been obtained by transmission electron microscopy, providing visual confirmation for Warburg’s seminal findings on the facultative anaerobiosis of neoplastic cells, and his observation that cell respiration is “structure bound”, i.e. intact inner mitochondrial cristae are a material requirement for oxidative phosphorylation [10-12]. Concerning ultrastructural abnormalities, our group has suggested the term crestodysmorphia to describe this peculiar morphological feature of cancer cells mitochondria. From the clinical perspective of competitive inhibition of the rate-limiting enzymes of solid tumors, it is semiologically relevant that neoplastic tissues show such a strong avidity for glucose, as ascertained semi-quantitatively by SUVmax calculations [Mbq Region of Interest/(Mbq injected/lean body mass)]. In this regard, PET-CT has provided proof-of-concept for a metabolic approach to cancer treatment. For diagnostic purposes, the cut-off has been conventionally set at ≥ 3 and reported measurements have been as high as 73 [13]. This last measurement implies a signal-to-noise ratio of 1 to 73, meaning the Region of Interest has a seventy-three fold increased avidity for glucose relative to surrounding healthy tissues.

The issue of brain fuel

In the medical lore, there is a deeply rooted belief that neurons can feed exclusively on glucose. Glycemic levels under 70 mg/dL are regarded, therefore, very dangerous and are vigorously corrected [14]. It seems to be common knowledge that blood glucose levels below 50 mg/dl “immediately trigger seizures”, with subsequent “irreversible brain damage" and so forth. However, central nervous system cells can perfectly extract energy through the oxidation of ketone bodies β-hydroxybutyrate (C4H7O3-) and acetoacetate (C4H5O3-), which serve as an alternative fuel during fasting and, conspicuously, even under a thorough removal of blood glucose [15-17]. Ketone bodies have even been shown to suppress glucose consumption by brain cells [18, 19]. The essential, in fact, the sine qua non, condition to make this clinical technique tolerable, is that, in the date of the procedure, the subject arrives in a state of physiological ketosis, having made the necessary transition or metabolic shift to a low glucose/high ketone state by means of caloric restriction, with fatty acids beta-oxidation already occurring in a steady state. Inadequate preparation could indeed result in a critical loss of all brain fuel, leading to seizures and neuronal damage [20, 21]. Having performed over twenty thousand such intravenous insulin clamps over the course of eleven years, on two thousand plus tumor-bearing patients, we recognize this procedure as feasible and safe. Furthermore, under proper conditions, even adverse reactions -should they occur- could easily be corrected within seconds by intravenous injection of 5cc of a standard hypertonic glucose solution. Further corrections could be made if needs be.

Materials and methods

Eighty-five patients, 47 females 38 males, were selected to evaluate their Critical Response Insulin Sensitivity (CRIS) index. Ages ranged from 35 to 72 years (= 53.6), all with a confirmed diagnosis of cancer, and a BMI ≥19, therefore susceptible to dietary restrictions. For the purpose of determining the effective personal dose (EPD) of insulin to be administered during each treatment session under the CISA protocol, a previous exploratory test was conducted to assess each patient overall organic status and insulin sensitivity, as well as their degree of compliance with the dietary restrictions necessary to enter a state of physiological ketosis. The data presented herein result from a subsequent, definitive test, administering the calculated full megadose of fast delivery insulin. Physiological ketosis, distinctly different from pathological ketoacidosis and hyperglycemic hyperosmolar syndrome (HHS) of decompensated diabetic patients, was defined as a ratio of ketone/glucose ≥0.03. Plasma pH in all 85 samples was 7.4 (± 0.1). Ketone bodies were measured with a commercial hand-held device, FreeStyle (Abbot). Peripheral blood samples for glucose measurements were collected in NaF tubes (0.86 mol/l). Quantitative glucose determination was performed by the enzymatic-Uv method using hexokinase, on the A15 Clinical Chemistry Analyzer (Biosystems).

The procedure routinely starts with the evaluation of the patient’s condition and quantification of physiological ketosis by the operator. Following catheterization of either the cephalic or basilic vein, a three-way stopcock with a Luer lock (Discofix) is attached to the Jelco catheter (Smith Medical), connecting an IV bag to the distal port. Once the intravenous route has been secured and kept permeable by a continuous drip (7 drops per minute) of isotonic saline solution 0.9% (B BRAUN) the operator proceeds to administer the corresponding dose of insulin (Lilly) -Humulin R, 100 IU x millilitre- in one single bolus injection. Within this group, the insulin EPD ranged from 20 IU to 70 IU (X=23, X = 25).

Close and constant attention was paid to developing signs and symptoms throughout the test by trained medical personnel. Measurements were taken at 7-minute intervals, carefully registering every discernible and/or referred changes in the patient’s state. Blood specimens were sent to our laboratory at a consistent pace, under the direct supervision of the technical director/chief technician in order to minimize preanalytical errors.

Recovery was induced through the ingestion of medium chain triglycerides and other fats, by means of a high fat/normal protein broth provided (drank at ≈ 60°C). Upon spontaneous normalization of blood glucose, once they regained total motor coordination and mental acuity and were perfectly capable of managing themselves unaided, patients were released to return home.

Before each individual test, written informed consent was obtained, and both patients and their close relatives were previously instructed in every instance on the necessary preparations and precautions.

On instrumental limitations and degree of uncertainty

The measurements of blood glucose we are reporting on were performed through the hexokinase method (margin of error ± 0,02 mg/dl), a transferase involved in the catalysis of hexoses by means of a reaction with adenosine triphosphate [22]. The low Km for hexokinase (10−5M or 0.9 mg/ %), allows it to operate at Vmax even at sub-physiological glucose concentrations, such as those expected during our tests. The quantitative measurement of glucose by the hexokinase-UV method, based on original work by Schmidt et al. and subsequently reproduced by Peterson and Young [23, 24] a long-established reference method based on the principle of exclusive substrate-enzyme interaction, provides higher specificity and sensitivity relative to conventional methods of quantitative glucose determination (GOD/PAP). For the measurement of blood ketones, commercial hand-held device FreeStyle (ABBOT), which has proven to perform consistently across many weeks of heavy use, was found to have a delta of 0.07 mg/dl.Eighty-five patients, 47 females 38 males, were selected to evaluate their Critical Response Insulin Sensitivity (CRIS) index. Ages ranged from 35 to 72 years (= 53.6), all with a confirmed diagnosis of cancer, and a BMI ≥19, therefore susceptible to dietary restrictions. For the purpose of determining the effective personal dose (EPD) of insulin to be administered during each treatment session under the CISA protocol, a previous exploratory test was conducted to assess each patient overall organic status and insulin sensitivity, as well as their degree of compliance with the dietary restrictions necessary to enter a state of physiological ketosis. The data presented herein result from a subsequent, definitive test, administering the calculated full megadose of fast delivery insulin. Physiological ketosis, distinctly different from pathological ketoacidosis and hyperglycemic hyperosmolar syndrome (HHS) of decompensated diabetic patients, was defined as a ratio of ketone/glucose ≥0.03. Plasma pH in all 85 samples was 7.4 (± 0.1). Ketone bodies were measured with a commercial hand-held device, FreeStyle (Abbot). Peripheral blood samples for glucose measurements were collected in NaF tubes (0.86 mol/l). Quantitative glucose determination was performed by the enzymatic-Uv method using hexokinase, on the A15 Clinical Chemistry Analyzer (Biosystems).

The procedure routinely starts with the evaluation of the patient’s condition and quantification of physiological ketosis by the operator. Following catheterization of either the cephalic or basilic vein, a three-way stopcock with a Luer lock (Discofix) is attached to the Jelco catheter (Smith Medical), connecting an IV bag to the distal port. Once the intravenous route has been secured and kept permeable by a continuous drip (7 drops per minute) of isotonic saline solution 0.9% (B BRAUN) the operator proceeds to administer the corresponding dose of insulin (Lilly) -Humulin R, 100 IU x millilitre- in one single bolus injection. Within this group, the insulin EPD ranged from 20 IU to 70 IU (= 23, X = 25).

Close and constant attention was paid to developing signs and symptoms throughout the test by trained medical personnel. Measurements were taken at 7-minute intervals, carefully registering every discernible and/or referred changes in the patient’s state. Blood specimens were sent to our laboratory at a consistent pace, under the direct supervision of the technical director/chief technician in order to minimize preanalytical errors.

Recovery was induced through the ingestion of medium chain triglycerides and other fats, by means of a high fat/normal protein broth provided (drank at ≈ 60°C). Upon spontaneous normalization of blood glucose, once they regained total motor coordination and mental acuity and were perfectly capable of managing themselves unaided, patients were released to return home.

Before each individual test, written informed consent was obtained, and both patients and their close relatives were previously instructed in every instance on the necessary preparations and precautions.

On instrumental limitations and degree of uncertainty

The measurements of blood glucose we are reporting on were performed through the hexokinase method (margin of error ± 0,02 mg/dl), a transferase involved in the catalysis of hexoses by means of a reaction with adenosine triphosphate [22]. The low Km for hexokinase (10−5M or 0.9 mg/ %), allows it to operate at Vmax even at sub-physiological glucose concentrations, such as those expected during our tests. The quantitative measurement of glucose by the hexokinase-UV method, based on original work by Schmidt et al. and subsequently reproduced by Peterson and Young [23, 24] a long-established reference method based on the principle of exclusive substrate-enzyme interaction, provides higher specificity and sensitivity relative to conventional methods of quantitative glucose determination (GOD/PAP). For the measurement of blood ketones, commercial hand-held device FreeStyle (ABBOT), which has proven to perform consistently across many weeks of heavy use, was found to have a delta of 0.07 mg/dl.

Results

Baseline beta-hydroxybutyrate levels at the beginning of the test ranged from 0,8 mmol/l to 8 mmol/l (= 4.9), while baseline blood glucose levels ranged from 38 mg/dL (1.8 mmol/) to 98 mg/dL (5.4 mmol/l) (= 68.9 mg/dl or 3.8 mmol/l). Tested at 7-minute intervals, subjects registered 3 to 11 measurements at the single-digit region (≤ 9 mg/dl, or 0.5 mmol/l). A minimum of 16 intervals was registered, with 85 patients remaining in the nuliglucaemia lucidae state (therefore, by definition, under the 18 mg/dl Abbot Glucometer threshold) for more than 9 intervals, or 63 minutes (Figure 1). The lowest glucose level registered was 2 mg/dl (0.1 mmol/l) (Figure 2). All patients remained lucid during the test, no adverse effects were registered.

Figure 1: Full blood glucose measurements for each subject (N=85) throughout 16 intervals.
Figure 2. “Japanese” candlesticks graph of glycemic measurements for all subjects. Glycemic range at each interval (all measurements registered).
Figure 3. Three examples of individual test blood samples, with detailed notations. The charts display insulinemia levels following megadose insulin -bolus injection- in a subset of 3 patients (random selection). Blood glucose levels were measured both through the Glucose Oxidase method (Abbot) -with inherent instrumental limitations- and the Hexokinase method (Biosystems). Highlighted in yellow, on the upper right corner of each chart, is the Critical Response Insulin Sensitivity (CRIS) index. The seven-fold variation in the CRIS index between patients 063-CM and 257-HP is not uncommon and is a strong predictor of treatment outcome.

On the Critical Response Insulin Sensitivity index

The Critical Response Insulin Sensitivity (CRIS) index (Individual test tables 1-3, upper right box), is a quantitative measure of the patient’s degree of insulin resistance assessed under conditions of deep physiological stress. Though similar to the alarm phase of the General Adaptation Syndrome first described by Selye et al. [25, 26], in this instance the critical response is not triggered by external stimuli but brought about by a megadose insulin challenge. Relative to the Oral Glucose Tolerance Test (OGTT), stress-testing the resistance of the host by a megadose intravenous insulin challenge truly explores the opposite end of the continuum of mammalian metabolism. This has proven to be of clinical relevance in tackling the cancer conundrum, characterized by hypermetabolic behavior. The standard OGTT explores the reverse to the mean from a state of glucose over-abundance, extrapolating data thus obtained to qualitatively assess the insulin sensitivity of the host. The CRIS index, conversely, uncovers much deeper aspects of the host physiology, thus helping in the design of a personalized, precise metabolic intervention. Interindividual differences of the CRIS index among tumour-bearing patients can vary by an order of magnitude. Throughout both instances -overabundance and total lack of glucose- several homeostatic mechanisms attempt a reverse to the mean, but the hormonal and biochemical responses involved are strikingly different. It is in the midst of the systemic perturbation brought about by such acute hormonal disruption that several physiological phenomena -not previously explored in regards to cancer treatment- can be taken advantage of. The calculation of the CRIS index is carried out by the following formula:

(IU of EPD/ Kg BWT patient)

------------------------------------------

(IU of EPD/ Kg BWT ideal subject)

where EPD = Effective Personal Dose -in International Units of potency-, the amount of insulin per kilogram of body weight (BWT) that brings about at least 4, but no more than 12, sequential blood glucose measurements <18>

Limitations of the study

Regrettably, these techniques offer no insight into the glutamine metabolism of the host. Given the complexity of tumor metabolism and the fact that glutamine has been found to be an important nutrient for neoplastic cells [27, 28] a parallel approach should be devised for clinicians to simultaneously assess glutaminemia, as well as the rate of glutamine catalysis into glutamate and alpha ketoglutarate within neoplastic tissues.

Conclusion

Absolute deprivation of blood glucose is achievable in the clinical setting at virtually no risk, provided protocol is strictly followed. For the purpose of enzymatic inhibition with antimetabolites of glucose, pyruvate and glutamine, a particular subpopulation of cancer patients with a BMI above 19, and under the age of 70 years could safely be induced in a state of nuliglucaemia lucidae. Intravenous, megadose, insulin-induced hypoglycemia provides a material advantage to the treatment of solid tumors by means of competitive inhibition with structural analogues. Incidental findings regarding a high correlation between the proprietor indicator CRIS index and survival has led us to believe that a population-wide screening tool for quantifying metabolic status could -and therefore should- be devised to allow for truly early detection of neoplastic disease.

References

Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.

img

Virginia E. Koenig

Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.

img

Delcio G Silva Junior

Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.

img

Ziemlé Clément Méda

Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.

img

Mina Sherif Soliman Georgy

We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.

img

Layla Shojaie

The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.

img

Sing-yung Wu

Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.

img

Orlando Villarreal

Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.

img

Katarzyna Byczkowska

Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.

img

Anthony Kodzo-Grey Venyo

Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.

img

Pedro Marques Gomes

Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.

img

Bernard Terkimbi Utoo

This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.

img

Prof Sherif W Mansour

Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.

img

Hao Jiang

As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.

img

Dr Shiming Tang

Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.

img

Raed Mualem

International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.

img

Andreas Filippaios

Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.

img

Dr Suramya Dhamija

Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.

img

Bruno Chauffert

I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!

img

Baheci Selen

"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".

img

Jesus Simal-Gandara

I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.

img

Douglas Miyazaki

We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.

img

Dr Griffith

I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.

img

Dr Tong Ming Liu

I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.

img

Husain Taha Radhi

I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.

img

S Munshi

Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.

img

Tania Munoz

“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.

img

George Varvatsoulias

Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.

img

Rui Tao

Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.

img

Khurram Arshad